Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tactile Systems Technology (TCMD)
:TCMD
RESEARCH TOOLSreports
Earnings Data
Report Date
May 12, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.08Last Year’s EPS
-0.05Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 18, 2025
|% Change Since: -15.73%
|Next Earnings Date:May 12, 2025
Earnings Call Sentiment|Positive
The earnings call reflects a positive outlook with strong revenue growth and strategic initiatives in place for 2025. However, there are challenges related to Medicare policy and increased operating expenses. The overall sentiment leans towards optimism with sustainable growth plans, but mindful of the challenges ahead.Company Guidance
During the fourth quarter and fiscal year 2024 earnings call for Tactile Medical, several key metrics and guidance for 2025 were outlined. The company reported total revenue of $293 million for 2024, representing a 6.8% growth year-over-year, with Q4 revenue specifically growing 10.2% to $85.6 million. The Lymphedema business line saw a 11% year-over-year increase in Q4, while Airway Clearance sales of AffloVest grew 3.8%. Gross margins improved by 310 basis points year-over-year, and adjusted EBITDA rose by 5.5%. The company anticipates 2025 revenue to range between $316 million and $322 million, marking an 8% to 10% growth. Tactile Medical plans to focus on three strategic initiatives aimed at improving market access, driving product innovation, and enhancing patient support throughout their care pathway. The company ended 2024 with $94.4 million in cash, reflecting a $12.2 million sequential increase.Strong Revenue Growth
Total revenue for 2024 was $293 million, representing a 6.8% growth year-over-year. Q4 revenue grew 10.2% year-over-year to $85.6 million.
Lymphedema Business Line Success
Sales grew 11% year-over-year in Q4 and were up 18.1% on a sequential basis. The launch of Nimbl for upper and lower extremity symptoms showed strong adoption.
Improved Gross Margins
Q4 gross margins increased 310 basis points year-over-year, driven by lower manufacturing and warranty costs.
Cash and Cash Equivalents Increase
Cash and cash equivalents increased sequentially by $12.2 million, closing the year with a $94.4 million cash balance.
Positive Adjusted EBITDA Growth
Adjusted EBITDA grew 5.5% year-over-year, reflecting another consecutive quarter of improvement.
Anticipated Revenue Growth in 2025
Projected full year 2025 revenue is in the range of $316 million to $322 million, representing an 8% to 10% year-over-year growth.
---
TCMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TCMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 18, 2025 | $17.86 | $15.49 | -13.27% |
| Nov 04, 2024 | $15.11 | $13.43 | -11.12% |
| Aug 05, 2024 | $11.54 | $13.14 | +13.86% |
| May 06, 2024 | $14.19 | $14.44 | +1.76% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Tactile Systems Technology (TCMD) report earnings?
Tactile Systems Technology (TCMD) is schdueled to report earning on May 12, 2025, TBA Not Confirmed.
What is Tactile Systems Technology (TCMD) earnings time?
Tactile Systems Technology (TCMD) earnings time is at May 12, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TCMD EPS forecast?
TCMD EPS forecast for the fiscal quarter 2025 (Q1) is -0.08.
---